Calcilytix Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Calcilytix Therapeutics's estimated annual revenue is currently $2.3M per year.
- Calcilytix Therapeutics's estimated revenue per employee is $155,000
- Calcilytix Therapeutics has 15 Employees.
- Calcilytix Therapeutics grew their employee count by 150% last year.
Calcilytix Therapeutics Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Calcilytix Therapeutics?
Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on developing a targeted therapy for disorders of calcium homeostasis. Our product candidate, encaleret, is an investigational orally-administered small molecule designed to specifically inhibit the calcium-sensing receptor, hypothesized to restore normal serum calcium and lower urine calcium.keywords:N/A
Number of Employees
Employee Growth %
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|